U.S. FDA Clears Dendreon Corporation's Prostate Cancer Vaccine Published: Apr 29, 2010 Reuters -- Dendreon Corp won U.S. approval on Thursday to sell a vaccine to treat men with advanced prostate cancer and the company's shares soared 15 percent. Related links Reuters This will open in a new window Xconomy This will open in a new window News Release This will open in a new window Email this Facebook Twitter LinkedIn Pinterest Reddit Back to news